Education
About Us
Working with TipRanks
Follow Us
PAPI - ETF AI Analysis
Top Page
Parametric Equity Premium Income ETF (PAPI)
Rating:70Neutral
Price Target:―
Positive Factors
Low Expense Ratio
The ETF has a relatively low expense ratio, making it cost-effective for investors.
Sector Diversification
The fund is spread across ten different sectors, reducing the impact of poor performance in any single industry.
Steady Three-Month Performance
The ETF has shown positive performance over the last three months, indicating recent momentum.
Negative Factors
High U.S. Concentration
With nearly all assets invested in U.S. companies, the fund lacks global diversification.
Underperforming Top Holdings
Several top holdings, such as Keurig Dr Pepper and Power Integrations, have experienced weak year-to-date performance.
Negative Year-to-Date Performance
The ETF has delivered negative returns so far this year, which may concern investors seeking growth.
PAPI vs. SPDR S&P 500 ETF (SPY)
AUM269.15M
RegionNorth America
Expense Ratio0.29%
Beta0.43
IssuerParametric
Inception DateOct 16, 2023
Dividend Yield7.54%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume61,158
30 Day Avg. Volume53,402
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
29.15Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering192
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PAPI Summary
The Parametric Equity Premium Income ETF (PAPI) is an investment fund that gives you exposure to a wide range of companies across the entire U.S. market. It includes well-known names like Johnson & Johnson and Gilead Sciences, and covers sectors such as technology, healthcare, and consumer goods. PAPI is designed to provide both growth and income, making it a good choice for investors who want diversification and steady income potential. However, since it tracks the overall market, its value can go up or down depending on how the market performs.
How much will it cost me?The Parametric Equity Premium Income ETF (PAPI) has an expense ratio of 0.29%, which means you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, using sophisticated strategies to optimize returns and generate premium income. Active management typically involves more research and trading, which increases costs.
What would affect this ETF?The Parametric Equity Premium Income ETF (PAPI) could benefit from positive trends in its key sectors, such as Technology and Health Care, which often thrive during periods of innovation and increased consumer demand. However, potential risks include economic slowdowns or rising interest rates, which could negatively impact sectors like Consumer Cyclical and Financials. Additionally, regulatory changes or geopolitical tensions in the U.S., where the ETF is focused, could create uncertainty for its holdings.
PAPI Top 10 Holdings
The Parametric Equity Premium Income ETF (PAPI) leans heavily on U.S. stocks, with a balanced mix across sectors like technology, consumer cyclical, and health care. Cardinal Health is rising as a standout performer, buoyed by strong earnings and cash flow, while UPS is lagging, weighed down by revenue growth challenges. Expeditors International and Cognizant are steady contributors, benefiting from strategic initiatives and AI-driven growth. With no single stock dominating the fund, PAPI’s diversified approach offers resilience, though its reliance on North American markets keeps its focus close to home.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 1.28% | $3.43M | ― | ― | ― | |
| LCI Industries | 0.77% | $2.05M | $2.99B | 19.23% | 79 Outperform | |
| Jack Henry & Associates | 0.73% | $1.94M | $13.41B | 4.66% | 77 Outperform | |
| Fox | 0.69% | $1.86M | $30.55B | 47.45% | 77 Outperform | |
| Cardinal Health | 0.69% | $1.86M | $49.27B | 74.51% | 66 Neutral | |
| Expeditors International | 0.69% | $1.84M | $20.32B | 36.39% | 80 Outperform | |
| Cummins | 0.68% | $1.83M | $71.38B | 46.13% | 72 Outperform | |
| Cognizant | 0.67% | $1.80M | $41.11B | 7.16% | 79 Outperform | |
| Steven Madden | 0.67% | $1.80M | $3.10B | 0.99% | 66 Neutral | |
| Bristol-Myers Squibb | 0.66% | $1.78M | $110.50B | -6.02% | 78 Outperform |
PAPI Technical Analysis
Positive
―
Price Trends
25.50
Positive
25.37
Positive
24.86
Positive
Market Momentum
0.15
Positive
55.00
Neutral
17.02
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PAPI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 25.88, equal to the 50-day MA of 25.50, and equal to the 200-day MA of 24.86, indicating a bullish trend. The MACD of 0.15 indicates Positive momentum. The RSI at 55.00 is Neutral, neither overbought nor oversold. The STOCH value of 17.02 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PAPI.
PAPI Peer Comparison
Comparison Results
Performance Comparison
PAPI
Parametric Equity Premium Income ETF
25.94
1.45
5.92%
PLDR
Putnam Sustainable Leaders ETF
―
―
―
SYLD
Cambria Shareholder Yield ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
EBI
Longview Advantage ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents